AISAP Cardio vs cvi42 Auto Imaging
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if you require rapid, AI-powered cardiac diagnostic assessments directly at the patient's bedside using point-of-care ultrasound. This tool is ideal for emergency medicine or cardiology settings where immediate screening for structural heart disease and heart failure is critical for early detection and quick clinical decision-making.
View AISAP Cardio →Choose cvi42 Auto Imaging if…
Choose cvi42 Auto Imaging if your workflow demands comprehensive, AI-powered analysis of advanced cardiovascular MR and CT images. This software excels in detailed plaque quantification, tissue characterization, and multi-modality support, making it suitable for in-depth diagnostic evaluation and treatment planning in a radiology or cardiology department.
View cvi42 Auto Imaging →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | cvi42 Auto Imaging |
|---|---|---|
| Pricing | Unknown | Starts at $5000 per license |
| Deployment | Cloud-based | On-premise (standalone workstation or client/server) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio is designed for point-of-care ultrasound (POCUS) and aims to empower clinicians with basic scanning skills to accurately diagnose cardiac conditions at the bedside within minutes. This focus on rapid, accessible diagnostics for a broader range of users, including non-cardiologists, suggests a higher degree of usability compared to cvi42 Auto Imaging, which requires qualified medical professionals experienced in evaluating MR or CT images.
Clinical Value
TieBoth tools offer significant clinical value in different contexts. AISAP Cardio, an FDA-cleared POCUS platform, provides rapid, comprehensive cardiac diagnostic assessments at the bedside, with 93% sensitivity and specificity for major valve diseases, enabling early detection and improved clinician performance. cvi42 Auto Imaging, also FDA-cleared, offers in-depth analysis of cardiovascular MR and CT images, including precise plaque quantification and advanced metrics for risk stratification, crucial for complex case management.
Pricing & Value
cvi42 Auto ImagingWhile neither tool publicly lists pricing, cvi42 Auto Imaging provides insights into potential reimbursement for its plaque analysis module (CPT 75577), indicating a clear path to revenue generation for healthcare providers. This transparency around potential return on investment, even without explicit pricing, offers a more tangible value proposition than AISAP Cardio, which has no public information regarding pricing or reimbursement pathways.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness. AISAP Cardio is a cloud-based SaaS platform, explicitly HIPAA-compliant and ISO-certified, with a BAA with AWS, and integrates with EHR/EMR/PACS. cvi42 Auto Imaging offers flexible deployment (on-premise, networked, cloud compatibility), multi-modality support, DICOM/HL7 connectivity, and holds ISO 13485:2016 and MDSAP certificates, with an emphasis on on-premise data control for PHI security.
Innovation
AISAP CardioAISAP Cardio stands out for its pioneering FDA clearance in the CADx pathway for comprehensive structural heart disease diagnosis using POCUS. Its innovation lies in democratizing advanced cardiac assessment by enabling non-cardiologists to perform accurate bedside diagnostics, significantly expanding access to expert-level insights and potentially transforming care pathways.
Support & Docs
cvi42 Auto Imagingcvi42 Auto Imaging provides comprehensive technical support, readily accessible documentation for various software versions (including user manuals and installation guides), and boasts high customer satisfaction scores. While AISAP Cardio offers contact information for support, it lacks the detailed public evidence of extensive documentation or customer satisfaction metrics that cvi42 Auto Imaging provides.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | cvi42 Auto Imaging |
|---|---|---|
| Name | AISAP Cardio | cvi42 Auto Imaging |
| Company | Aisap | Circle Cardiovascular Imaging |
| Description | FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows. |
| Primary Modality | Ultrasound (POCUS) | Cardiovascular MR and CT |
| Key Features (Cardiac Disease Detection) | AI-powered interpretation for early cardiac disease detection, assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), measurement of Left Ventricle Ejection Fraction (LVEF), measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. | Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain), Cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment), Quantitative analysis (volume, mass, function, signal intensity, plaque). |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and cvi42 Auto Imaging.